{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T21:20:08Z","timestamp":1790630408887,"version":"4.1.0"},"reference-count":28,"publisher":"Spandidos Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.3892\/mmr.2014.2804","type":"journal-article","created":{"date-parts":[[2014,10,29]],"date-time":"2014-10-29T09:26:02Z","timestamp":1414574762000},"page":"1528-1534","source":"Crossref","is-referenced-by-count":51,"title":["Increased serum amyloid A and its association with autoantibodies, acute phase reactants and disease activity in patients with rheumatoid arthritis"],"prefix":"10.3892","volume":"11","author":[{"given":"CHEN","family":"SHEN","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"XU-GUO","family":"SUN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"NA","family":"LIU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YUN","family":"MU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"CHENG-CHENG","family":"HONG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"WEI","family":"WEI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"FANG","family":"ZHENG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2014,10,29]]},"reference":[{"key":"key20180108001441_b1-mmr-11-02-1528","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/S0140-6736(10)60826-4","article-title":"Rheumatoid arthritis","volume":"376","author":"Scott","year":"2010","journal-title":"Lancet"},{"key":"key20180108001441_b2-mmr-11-02-1528","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1056\/NEJMra1004965","article-title":"The pathogenesis of rheumatoid arthritis","volume":"365","author":"McInnes","year":"2011","journal-title":"N Engl J Med"},{"key":"key20180108001441_b3-mmr-11-02-1528","first-page":"3","article-title":"Evidence supporting the benefit of early intervention in rheumatoid arthritis","volume":"66","author":"Emery","year":"2002","journal-title":"J Rheumatol"},{"issue":"5 Suppl 39","key":"key20180108001441_b4-mmr-11-02-1528","first-page":"S93","article-title":"The disease activity score and the EULAR response criteria","volume":"23","author":"Fransen","year":"2005","journal-title":"Clin Exp Rheumatol"},{"key":"key20180108001441_b5-mmr-11-02-1528","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1002\/art.24123","article-title":"EULAR, ACR: Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR\/ACR collaborative recommendations","volume":"59","author":"Aletaha","year":"2008","journal-title":"Arthritis Rheum"},{"key":"key20180108001441_b6-mmr-11-02-1528","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1136\/ard.2006.063834","article-title":"Disease Activity Score 28 (DAS28) using C-reactive protein underestimates disease activity and overestimates EULAR response criteria compared with DAS28 using erythrocyte sedimentation rate in a large observational cohort of rheumatoid arthritis patients in Japan","volume":"66","author":"Matsui","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"key20180108001441_b7-mmr-11-02-1528","first-page":"375","article-title":"Laboratory characteristics of a cohort of patients with early rheumatoid arthritis","volume":"50","author":"Da Mota","year":"2010","journal-title":"Rev Bras Rheumatol"},{"key":"key20180108001441_b8-mmr-11-02-1528","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.27584","article-title":"2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"62","author":"Aletaha","year":"2010","journal-title":"Arthritis Rheum"},{"key":"key20180108001441_b9-mmr-11-02-1528","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s12016-007-8018-1","article-title":"Does the presence of anti-CCP autoantibodies and their serum levels influence the severity and activity in rheumatoid arthritis patients?","volume":"34","author":"Papadopoulos","year":"2008","journal-title":"Clin Rev Allergy Immunol"},{"key":"key20180108001441_b10-mmr-11-02-1528","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/art.21518","article-title":"Acute-phase serum amyloid A stimulation of angiogenesis, leukocyte recruitment, and matrix degradation in rheumatoid arthritis through an NF-\u03baB-dependent signal transduction pathway","volume":"54","author":"Mullan","year":"2006","journal-title":"Arthritis Rheum"},{"key":"key20180108001441_b11-mmr-11-02-1528","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.2119\/molmed.2011.00186","article-title":"Serum amyloid A directly accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice","volume":"17","author":"Dong","year":"2011","journal-title":"Mol Med"},{"key":"key20180108001441_b12-mmr-11-02-1528","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1615\/CritRevImmunol.v32.i4.40","article-title":"Immune functions of serum amyloid A","volume":"32","author":"Eklund","year":"2012","journal-title":"Crit Rev Immunol"},{"key":"key20180108001441_b13-mmr-11-02-1528","doi-asserted-by":"crossref","first-page":"218","DOI":"10.3349\/ymj.2007.48.2.218","article-title":"Serum amyloid a as a useful indicator of disease activity in patients with ankylosing spondylitis","volume":"48","author":"Jung","year":"2007","journal-title":"Yonsei Med J"},{"key":"key20180108001441_b14-mmr-11-02-1528","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.3349\/ymj.2012.53.5.1045","article-title":"Serum amyloid A circulating levels and disease activity in patients with juvenile idiopathic arthritis","volume":"53","author":"Cantarini","year":"2012","journal-title":"Yonsei Med J"},{"key":"key20180108001441_b15-mmr-11-02-1528","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.2169\/internalmedicine.44.1009","article-title":"Serum amyloid A as a potent therapeutic marker in a refractory patient with polymyalgia rheumatica","volume":"44","author":"Shimojima","year":"2005","journal-title":"Intern Med"},{"key":"key20180108001441_b16-mmr-11-02-1528","first-page":"14","article-title":"Three-year follow-up of interleukin 6 and C-reactive protein in chronic obstructive pulmonary disease","volume":"20","author":"Ferrari","year":"2013","journal-title":"Respir Res"},{"key":"key20180108001441_b17-mmr-11-02-1528","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/ar78","article-title":"Acute-phase serum amyloid A production by rheumatoid arthritis synovial tissue","volume":"2","author":"O\u2019Hara","year":"2000","journal-title":"Arthritis Res"},{"key":"key20180108001441_b18-mmr-11-02-1528","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.cca.2008.07.034","article-title":"Chondrocyte of rheumatoid arthritis serve as a source of intra-articular acute-phase serum amyloid A protein","volume":"398","author":"Momohara","year":"2008","journal-title":"Clin Chim Acta"},{"key":"key20180108001441_b19-mmr-11-02-1528","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.4049\/jimmunol.166.4.2801","article-title":"Serum amyloid A (apoSAA) expression is up-regulated in rheumatoid arthritis and induces transcription of matrix metalloproteinases","volume":"66","author":"Vallon","year":"2001","journal-title":"J Immunol"},{"key":"key20180108001441_b20-mmr-11-02-1528","doi-asserted-by":"crossref","first-page":"e66769","DOI":"10.1371\/journal.pone.0066769","article-title":"Acute-phase serum amyloid a in osteoarthritis: regulatory mechanism and proinflammatory properties","volume":"8","author":"de Seny","year":"2013","journal-title":"PloS One"},{"key":"key20180108001441_b21-mmr-11-02-1528","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1007\/s10067-011-1737-y","article-title":"Serum and synovial fluid levels of interleukin-17 in correlation with disease activity in patients with RA","volume":"30","author":"Metawi","year":"2011","journal-title":"Clin Rheumatol"},{"key":"key20180108001441_b22-mmr-11-02-1528","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1093\/rheumatology\/kep089","article-title":"Serum amyloid A protein stimulates CCL20 production in rheumatoid synoviocytes","volume":"48","author":"Migita","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"key20180108001441_b23-mmr-11-02-1528","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/art.21518","article-title":"Acute-phase serum amyloid A stimulation of angiogenesis, leukocyte recruitment, and matrix degradation in rheumatoid arthritis through an NF-\u03baB-dependent signal transduction pathway","volume":"54","author":"Mullan","year":"2006","journal-title":"Arthritis Rheum"},{"key":"key20180108001441_b24-mmr-11-02-1528","first-page":"752","article-title":"Serum amyloid A activates nuclear factor-kappa B in rheumatoid synovial fibroblasts through binding to receptor of advanced glycation end-products","volume":"35","author":"Okamoto","year":"2008","journal-title":"J Rheumatol"},{"issue":"9 Suppl B","key":"key20180108001441_b25-mmr-11-02-1528","doi-asserted-by":"crossref","first-page":"S09","DOI":"10.18553\/jmcp.2011.17.s9-b.S09","article-title":"Assessment of disease activity and treatment outcomes in rheumatoid arthritis","volume":"17","author":"Farheen","year":"2011","journal-title":"J Manag Care Pharm"},{"key":"key20180108001441_b26-mmr-11-02-1528","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1002\/art.33455","article-title":"Acute-phase serum amyloid A regulates tumor necrosis factor \u03b1 and matrix turnover and predicts disease progression in patients with inflammatory arthritis before and after biologic therapy","volume":"64","author":"Connolly","year":"2012","journal-title":"Arthritis Rheum"},{"key":"key20180108001441_b27-mmr-11-02-1528","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.0300-9475.2004.01369.x","article-title":"Regulation of the human acute phase serum amyloid A genes by tumour necrosis factor-alpha, interleukin-6 and glucocorticoids in hepatic and epithelial cell lines","volume":"59","author":"Thorn","year":"2004","journal-title":"Scand J Immunol"},{"key":"key20180108001441_b28-mmr-11-02-1528","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s10067-006-0275-5","article-title":"Autoantibodies in rheumatoid arthritis: association with severity of disease in established RA","volume":"26","author":"Agrawal","year":"2007","journal-title":"Clin Rheumatol"}],"container-title":["Molecular Medicine Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/mmr.2014.2804\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,20]],"date-time":"2022-04-20T20:59:24Z","timestamp":1650488364000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/mmr.2014.2804"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,29]]},"references-count":28,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2014,10,29]]},"published-print":{"date-parts":[[2015,2]]}},"alternative-id":["10.3892\/mmr.2014.2804"],"URL":"https:\/\/doi.org\/10.3892\/mmr.2014.2804","relation":{},"ISSN":["1791-2997","1791-3004"],"issn-type":[{"value":"1791-2997","type":"print"},{"value":"1791-3004","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,29]]}}}